Transthyretin is involved in depression-like behaviour and exploratory activity

Journal of Neurochemistry

Volumn 88, Issue 5, 2004, Pages 1052-1058

  Carlos Sousa, João ^a,b   Grandela, Catarina ^a   Fernández Ruiz, Javier ^c   De Miguel, Rosário ^c   De Sousa, Liliana ^a,b   Magalhães, Ana Isabel ^a,b   João Saraiva, Maria ^a,b   Sousa, Nuno ^d   Palha, Joana Almeida ^a,d  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d UNIVERSITY OF MINHO   (Portugal)

Author keywords

Behaviour; Norepinephrine; Retinoids; Thyroid hormone; Thyroxine; Transthyretin

Indexed keywords

ALZHEIMER BETA PEPTIDE; CATECHOLAMINE; NORADRENALIN; PEPTIDE; PREALBUMIN; RETINOL; THYROID HORMONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; DEPRESSION; EXPLORATORY BEHAVIOR; FEMALE; HORMONE TRANSPORT; LIMBIC CORTEX; MALE; MENTAL DISEASE; MOUSE; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BEHAVIOR, ANIMAL; DEPRESSION; DEPRESSIVE DISORDER; DOPAMINE; EXPLORATORY BEHAVIOR; FEMALE; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; MICE; MICE, KNOCKOUT; NOREPINEPHRINE; PHENOTYPE; PREALBUMIN; PROSENCEPHALON; SPATIAL BEHAVIOR;

ANIMALIA;

EID: 1442299424     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.02309.x     Document Type: Article

References (38)

1. Anderson G. W. (2001) Thyroid hormones and the brain. Front Neuroendocrinol. 22, 1-17.
2. Balmer J. E. and Blomhoff R. (2002) Gene expression regulation by retinoic acid. J. Lipid Res. 43, 1773-1808.
3. Bauer M., Heinz A. and Whybrow P. C. (2002) Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol. Psychiatry 7, 140-156.
4. Bernal J. (2002) Action of thyroid hormone in brain. J. Endocrinol. Invest. 25, 268-288.
5. Bolivar V., Cook M. and Flaherty L. (2000) List of transgenic and knockout mice: behavioral profiles. Mamm. Genome 11, 260-274.
6. Boomsma F., Man in 'T. Veld A. J. and Schalekamp M. A. (1991) Not norepinephrine but its oxidation products bind specifically to plasma proteins. J. Pharm. Exp. Therap. 259, 551-557.
7. Carro E., Trejo J. L., Gomez-Isla T., LeRoith D. and Torres-Aleman I. (2002) Serum insulin-like growth factor I regulates brain amyloid-β levels. Nat. Med. 8, 1390-1397.
8. Episkopou V., Maeda S., Nishiguchi S., Shimada K., Gaitanaris G. A., Gottesman M. E. and Robertson E. J. (1993) Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc. Natl Acad. Sci. USA 90, 2375-2379.
9. Ernström U., Petterson T. and Jörnvall H. (1995) A yellow component associated with human transthyretin has properties like a pterin derivate, 7, 8-dihydropterin-6-carboxaldehyde. FEBS Lett. 360, 177-182.
10. File S. E., Lippa A. S., Beer B. and Lippa M. T. (2000) Animal tests of anxiety. In: Current Protocols in Neuroscience (Taylor G. P., ed.), pp. 8.3.1-8.3.19. John Wiley & Sons, Inc, New York.
11. González S., Romero J., de Miguel R., Lastres-Becker I., Villanua M. A., Makriyannis A., Ramos J. A. and Fernandez-Ruiz J. J. (1999) Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide. Life Sci. 65, 327-336.
12. Hagen G. A. and Elliott W. J. (1973) Transport of thyroid hormones in serum and cerebrospinal fluid. J. Clin. Endocrinol. 37, 415-422.
13. Kabat E. A., Moore D. H. and Landow H. (1942) An electrophoretic study of the protein components in cerebrospinal fluid and their relationship to the serum proteins. J. Clin. Invest. 21, 571-577.
14. Kim H. S., Hong S. J., LeDoux M. S. and Kim K. S. (2001) Regulation of the tyrosine hydroxylase and dopamine β-hydroxylase genes by the transcription factor AP-2. J. Neurochem. 76, 280-294.
15. Morriss-Kay G. M. and Ward S. J. (1999) Retinoids and mammalian development. Int. Rev. Cytol. 188, 73-130.
16. Nagatsu T., Oka K. and Kato T. (1979) Highly sensitive assay for tyrosine hydroxylase activity by high-performance liquid chromatography. J. Chromat. 163, 247-252.
17. Palha J. A. (2002) Transthyretin as a thyroid hormone carrier: a function revisited. Clin. Chem. Lab. Med. 40, 1292-1300.
18. Palha J. A., Episkopou V., Maeda S., Shimada K., Gottesman M. E. and Saraiva M. J. (1994) Thyroid hormone metabolism in a transthyretin-null mouse strain. J. Biol. Chem. 269, 33135-33139.
19. Palha J. A., Moreira P., Wisniewski T., Frangione B. and Saraiva M. J. (1996) Transthyretin gene in Alzheimer's disease patients. Neurosc. Lett. 204, 212-214.
20. Palha J. A., Hays M. T., Morreale de Escobar G., Episkopou V., Gottesman M. E. and Saraiva M. J. (1997) Transthyretin is not essential for thyroxine to reach the brain and other tissues in a transthyretin null mouse strain. Am. J. Physiol. 272, E485-E493.
21. Palha J. A., Fernandes R., Morreale de Escobar G., Episkopou V., Gottesman M. and Saraiva M. J. (2000) Transthyretin regulates thyroid hormone levels in the choroid plexus but not in the brain parenchyma: study in a transthyretin-null mouse model. Endocrinology 141, 3267-3272.
22. Palha J. A., Nissanov J., Fernandes R. et al.. (2002) Thyroid hormone distribution in the mouse brain: the role of transthyretin. Neuroscience 113, 837-842.
23. Pêgo J. M., Cerqueira J. J., Palha J. and Sousa N. (2003) Morphological changes in the basolateral division of the amygdala of TTR-null mice. In: Sixt IBRO World Congress of Neuroscience. Abstract book, pp 207, number 2265, Prague.
24. Plaznik A., Danysz W. and Kostowski W. (1985a) A stimulatory effect of intraaccumbens injecfions of noradrenaline on the behavior of rats in the forced swim test. Psychopharmacology 87, 119-123.
25. Plaznik A., Danysz W. and Kostowski W. (1985b) Some behavioral effects of microinjecfions of noradrenaline and serotonin into the amygdaloid body of the rat brain. Physiol. Behav. 34, 481-487.
26. Porsolt R. D., Bertin A. and Jalfre M. (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229, 327-336.
27. Porsolt R. D., Anton G., Blavet N. and Jalfre M. (1978) Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47, 379-391.
28. Porsolt R. D., Bertin A., Blavet N., Deniel M. and Jalfre M. (1979) Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur J. Pharmacol. 57, 201-210.
29. Pulford D. J., Henry B., Adams F., Harries D. N., Mallinson D. J., Reid I. C. and Stewart C. A. (2002) Chronic administration of lithium chloride down-regulates transthyretin mRNA expression in rat brain. In: Society for Neuroscience 32nd Annual Meeting. Abstract Viewer/Itinerary Planner Program No. 308.2. Society for Neuroscience, Washington, DC. Online.
30. Riisoen H. (1988) Reduced pre-albumin (transthyretin) in CSF of severely demented patients with Alzheimer's disease. Acta Neurol. Scand. 78, 455-459.
31. Rodrigues-Pena A. (1999) Oligodendrocyte development and thyroid hormone. J. Neurobiol. 40, 497-512.
32. Romero J., de Miguel R., García-Palomero E., Ferná ndez-Ruiz J. J. and Ramos J. A. (1995) Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function. Brain Res. 694, 223-232.
33. Schreiber G., Southwell B. R. and Richardson S. J. (1995) Hormone delivery systems to the brain transthyretin. Exp. Clin. Endocrinol. 103, 75-80.
34. Schwarzman A. L., Gregori L., Vitek M. P. et al. (1994) Transthyretin sequesters amyloid β-protein and prevents amyloid formation. Proc. Natl Acad. Sci. USA 91, 8368-8372.
35. Smith D., Wagner E., Koul O., McCaffery P. and Drager U. C. (2001) Retinoic acid synthesis for the developing telencephalon. Cereb. Cortex 11, 894-905.
36. Southwell B. R., Duan W., Alcorn D., Brack C., Richardson S. J., Kohrle J. and Schreiber G. (1993) Thyroxine transport to the brain: role of protein synthesis by the choroid plexus. Endocrinology 133, 2116-2226.
37. Stein T. D. and Johnson J. A. (2002) Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J. Neurosci. 22, 7380-7388.
38. Sullivan G. M., Hatterer J. A., Herbert J. et al. (1999) Low levels of transthyretin in the CSF of depressed patients. Am. J. Psychiatry 156, 710-715.